# Aino Co., Ltd. of North China Pharma. Group – FDA Inspection, Nov 18, 2011

Source: https://www.keypedia.com/records/fda_inspections/aino-co-ltd-of-north-china-pharma-group/f38f267e-965e-4d79-be04-0603d5a0db68
Source feed: FDA_Inspections

> FDA inspection 754952 of Aino Co., Ltd. of North China Pharma. Group, November 18, 2011. Classification: Voluntary Action Indicated (VAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 754952
- Company Name: Aino Co., Ltd. of North China Pharma. Group
- Inspection Date: 2011-11-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1267899 - 2025-03-14
- [FDA Inspection 1078188 - 2019-01-17](https://www.keypedia.com/records/fda_inspections/aino-co-ltd-of-north-china-pharma-group/50583955-aa41-407b-bca3-452c0798068b)
- [FDA Inspection 972459 - 2016-04-29](https://www.keypedia.com/records/fda_inspections/aino-co-ltd-of-north-china-pharma-group/f731ed10-97ff-49d5-a968-9fd01310fdd1)
- FDA Inspection 888168 - 2014-06-06
- FDA Inspection 598515 - 2009-07-02

Company: https://www.keypedia.com/companies/aino-co-ltd-of-north-china-pharma-group/e6d7882f-44c2-4550-bbec-b76d137da6f2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c